ArticleScientific reports2017

The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients.

John Palmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.